Abstract
Controversial reports exist regarding the administration of spinal anesthesia in achondroplastic dwarfs regarding safety, dose, drug choice, in obstetric patients. Bony characteristics such as vertebral anomalies, lordosis and lumbar scoliosis, limited mouth opening and cervical spine instability make the administration of anesthesia to these patients truly a challenge. Here we demonstrate that low dose meperidine and bupivacaine spinal anesthesia in an achondroplastic parturient for ceserean section, was administered successfully after careful evaluation, consideration of risks, and awareness of potential complications.
Keywords: Achondroplasia, ceserean section, spinal anesthesia, bone deformities, lumbar lordosis, metochlopramide, Meperidine, bupivacaine
Current Drug Safety
Title: Safety of Spinal Anesthesia in a Patient with Achondroplasia for Cesarean Section
Volume: 6 Issue: 2
Author(s): Hosni Mikhael, Nalini Vadivelu and Ferne Braveman
Affiliation:
Keywords: Achondroplasia, ceserean section, spinal anesthesia, bone deformities, lumbar lordosis, metochlopramide, Meperidine, bupivacaine
Abstract: Controversial reports exist regarding the administration of spinal anesthesia in achondroplastic dwarfs regarding safety, dose, drug choice, in obstetric patients. Bony characteristics such as vertebral anomalies, lordosis and lumbar scoliosis, limited mouth opening and cervical spine instability make the administration of anesthesia to these patients truly a challenge. Here we demonstrate that low dose meperidine and bupivacaine spinal anesthesia in an achondroplastic parturient for ceserean section, was administered successfully after careful evaluation, consideration of risks, and awareness of potential complications.
Export Options
About this article
Cite this article as:
Mikhael Hosni, Vadivelu Nalini and Braveman Ferne, Safety of Spinal Anesthesia in a Patient with Achondroplasia for Cesarean Section, Current Drug Safety 2011; 6 (2) . https://dx.doi.org/10.2174/157488611795684668
DOI https://dx.doi.org/10.2174/157488611795684668 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia
Current Cancer Drug Targets Sleep Duration as a Risk Factor for Cardiovascular Disease- a Review of the Recent Literature
Current Cardiology Reviews The Application of Chitosan and Its Derivatives as Nanosized Carriers for the Delivery of Chemical Drugs and Genes or Proteins
Current Drug Targets Mesoionic Oxatriazoles (MOTA): NO-Donating Characteristics and Pharmacology
Current Pharmaceutical Design The Cancer Related Thrombotic Tendency in Sepsis
Current Drug Targets A Critical Review on the Unexplored Therapeutic Treasure of Himalayan Ayurvedic Drug Daruharidra (<i>Berberis Aristata</i>)
Current Traditional Medicine Ranolazine, a Partial Fatty Acid Oxidation Inhibitor, its Potential Benefit in Angina and Other Cardiovascular Disorders
Recent Patents on Cardiovascular Drug Discovery Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease
Current Vascular Pharmacology Neuroprotection by Alpha 2-Adrenergic Agonists in Cerebral Ischemia
Current Neuropharmacology Treatment of Leukoaraiosis: A Futuristic View
Current Drug Targets Essential Hypertension: Translating Pathophysiology into Pharmacogenomics
Current Pharmacogenomics Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function
Current Neuropharmacology Inhibition of Renin-Angiotensin System and Advanced Glycation End Products Formation: A Promising Therapeutic Approach Targeting on Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Potential Implications of Angiotensin-converting Enzyme 2 Blockades on Neuroinflammation in SARS-CoV-2 Infection
Current Drug Targets From Amino Acids to Proteins as Targets for Metal-based Drugs
Current Drug Metabolism Nocturia in Obstructive Sleep Apnea-Hypopnea Syndrome: An Underappreciated Symptom
Current Respiratory Medicine Reviews Atypical Presentation Of Anti-Retroviral Therapy Induced Lactic Acidosis as Acute Right Ventricular Failure And Severe Pulmonary Hypertension
New Emirates Medical Journal Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant Prescription
Current Drug Metabolism Design and Synthesis of Dopaminergic Agonists
Current Medicinal Chemistry TNF alpha Inhibition as Treatment Modality for Certain Rheumatologic and Gastrointestinal Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets